Home
About
About us
2021 Top Achievements
Leonhardt Ventures Portfolio Clinical Trials Listing
Founder Bio
Development Pipeline
Regenerative Medtech
Media
Company Logos
LV Team
Board of Directors
Team
Accelerator Core Team
Portfolio Startups Boards
Scientific Advisory Board
Our Startups
News
Investors
Invest in us
Agreements & Forms
Agreement Forms
Master Patent IP License and Development Agreement
Accelerator Membership Agreement
Term Sheet
409a Valuation Accelerator
Simple Agreement for Future Equity
Simple Agreement for Future Equity – Word
Simple Agreement for Future Equity – PDF
Leonhardts Launchpads
Leonhardt’s Launchpads Valuations
Accelerator Business Model
Cap Tables and Valuations
Important
2023 Budget
2022 Budget
2022 Compared YTD Budget
Legal Terms Summary
Executive Chairman’s 2022 Update
Executive Chairman’s Best guess estimate June 2022 on portfolio assets closest to exit
Board Governance
2023 Goals
Current Clinical Trials
Executive Summary
Clinical Studies
Clinical Study Enrollment 10/1/19
Annual Reports
2020-2023
2023 Annual Report
Mid-Year 2022 Semi-Annual Report
2022 Annual Report Executive Summary
2021 Annual Report
2020 Annual Report
2016 – 2019
2019 Annual Report
2018 Annual Report
2017 Annual Report
2016 Annual Report
2012-2015
2015/16 Annual report
1Q 2015 Newsletter
2013/14 Annual Newsletter
2012 Fall Newsletter
Investor FAQ
Leonhardt Ventures LLC Patent Licenses 2022
Contact
Select Page
CANCER TREATMENT
CancerCell
bioelectric cancer tumor treatment + regeneration
STAGE
PRE-CLINICAL
